These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 20837713)
1. Mycobacterium tuberculosis synergizes with ATP to induce release of microvesicles and exosomes containing major histocompatibility complex class II molecules capable of antigen presentation. Ramachandra L; Qu Y; Wang Y; Lewis CJ; Cobb BA; Takatsu K; Boom WH; Dubyak GR; Harding CV Infect Immun; 2010 Dec; 78(12):5116-25. PubMed ID: 20837713 [TBL] [Abstract][Full Text] [Related]
2. P2X7 receptor-stimulated secretion of MHC class II-containing exosomes requires the ASC/NLRP3 inflammasome but is independent of caspase-1. Qu Y; Ramachandra L; Mohr S; Franchi L; Harding CV; Nunez G; Dubyak GR J Immunol; 2009 Apr; 182(8):5052-62. PubMed ID: 19342685 [TBL] [Abstract][Full Text] [Related]
4. Bacterial Membrane Vesicles Mediate the Release of Mycobacterium tuberculosis Lipoglycans and Lipoproteins from Infected Macrophages. Athman JJ; Wang Y; McDonald DJ; Boom WH; Harding CV; Wearsch PA J Immunol; 2015 Aug; 195(3):1044-53. PubMed ID: 26109643 [TBL] [Abstract][Full Text] [Related]
5. Alternate class I MHC antigen processing is inhibited by Toll-like receptor signaling pathogen-associated molecular patterns: Mycobacterium tuberculosis 19-kDa lipoprotein, CpG DNA, and lipopolysaccharide. Tobian AA; Potter NS; Ramachandra L; Pai RK; Convery M; Boom WH; Harding CV J Immunol; 2003 Aug; 171(3):1413-22. PubMed ID: 12874233 [TBL] [Abstract][Full Text] [Related]
6. Role of phagosomes and major histocompatibility complex class II (MHC-II) compartment in MHC-II antigen processing of Mycobacterium tuberculosis in human macrophages. Torres M; Ramachandra L; Rojas RE; Bobadilla K; Thomas J; Canaday DH; Harding CV; Boom WH Infect Immun; 2006 Mar; 74(3):1621-30. PubMed ID: 16495533 [TBL] [Abstract][Full Text] [Related]
7. Rapid loss of early antigen-presenting activity of lymph node dendritic cells against Ag85A protein following Mycobacterium bovis BCG infection. Xu Z; Xia A; Li X; Zhu Z; Shen Y; Jin S; Lan T; Xie Y; Wu H; Meng C; Sun L; Yin Y; Chen X; Jiao X BMC Immunol; 2018 Jun; 19(1):19. PubMed ID: 29940854 [TBL] [Abstract][Full Text] [Related]
8. Processing of Mycobacterium tuberculosis antigen 85B involves intraphagosomal formation of peptide-major histocompatibility complex II complexes and is inhibited by live bacilli that decrease phagosome maturation. Ramachandra L; Noss E; Boom WH; Harding CV J Exp Med; 2001 Nov; 194(10):1421-32. PubMed ID: 11714749 [TBL] [Abstract][Full Text] [Related]
9. Mycobacterium tuberculosis inhibits MHC class II antigen processing in murine bone marrow macrophages. Noss EH; Harding CV; Boom WH Cell Immunol; 2000 Apr; 201(1):63-74. PubMed ID: 10805975 [TBL] [Abstract][Full Text] [Related]
10. Recombinant Lipoprotein Rv1016c Derived from Su H; Zhu S; Zhu L; Huang W; Wang H; Zhang Z; Xu Y Front Cell Infect Microbiol; 2016; 6():147. PubMed ID: 27917375 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of major histocompatibility complex II expression and antigen processing in murine alveolar macrophages by Mycobacterium bovis BCG and the 19-kilodalton mycobacterial lipoprotein. Fulton SA; Reba SM; Pai RK; Pennini M; Torres M; Harding CV; Boom WH Infect Immun; 2004 Apr; 72(4):2101-10. PubMed ID: 15039332 [TBL] [Abstract][Full Text] [Related]
13. Mycobacterium tuberculosis PPE18 protein inhibits MHC class II antigen presentation and B cell response in mice. Dolasia K; Nazar F; Mukhopadhyay S Eur J Immunol; 2021 Mar; 51(3):603-619. PubMed ID: 33084017 [TBL] [Abstract][Full Text] [Related]
14. Suboptimal Antigen Presentation Contributes to Virulence of Mycobacterium tuberculosis In Vivo. Grace PS; Ernst JD J Immunol; 2016 Jan; 196(1):357-64. PubMed ID: 26573837 [TBL] [Abstract][Full Text] [Related]
15. Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection. Mazzaccaro RJ; Gedde M; Jensen ER; van Santen HM; Ploegh HL; Rock KL; Bloom BR Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11786-91. PubMed ID: 8876215 [TBL] [Abstract][Full Text] [Related]
16. Exosomes derived from M. Bovis BCG infected macrophages activate antigen-specific CD4+ and CD8+ T cells in vitro and in vivo. Giri PK; Schorey JS PLoS One; 2008 Jun; 3(6):e2461. PubMed ID: 18560543 [TBL] [Abstract][Full Text] [Related]